Matthew Meriggioli to Biomimetics
This is a "connection" page, showing publications Matthew Meriggioli has written about Biomimetics.
Connection Strength
0.039
-
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial. Lancet Neurol. 2018 12; 17(12):1043-1052.
Score: 0.039